您的位置: 首页 > 农业专利 > 详情页

SEQUENCES HCBI, MSBI, MSSI ET CMI UTILISABLES EN TANT QUE MARQUEURS PRECOCES DU FUTUR DEVELOPPEMENT D'UN CANCER ET DE MALADIES DU SNC ET EN TANT QUE CIBLES POUR LE TRAITEMENT ET LA PREVENTION DE CES MALADIES
专利权人:
DEUTSCHES KREBSFORSCHUNGSZENTRUM
发明人:
DE VILLIERS-ZUR HAUSEN, ETHEL-MICHELE,ZUR HAUSEN, HARALD,GUNST, KARIN,WHITLEY, CORINNA,PEREZ, IRANZU LAMBERTO
申请号:
CA2954541
公开号:
CA2954541A1
申请日:
2015.07.09
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
Described are HCBI (Healthy Cattle Blood Isolate), MSBI (Multiple Sclerosis Brain Isolate), MSSI (Multiple Sclerosis Serum Isolate) and CMI (Cow Milk Isolate) nucleotide sequences as well as probes and primers comprising part of said nucleotide sequences and antibodies against polypeptides encoded by said nucleotide sequences. Said compounds are useful as early markers for the future development of cancer and diseases of the CNS (Multiple sclerosis MS, Prion-linked diseases, amyotrophic lateral sclerosis, transmissible spongiforme encephalitis, Parkinson's disease, Alzheimer disease) and should represent targets for treatment and prevention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充